Lung volume reduction surgery involves the removal of emphysematous lung ti
ssue with the aim of palliating symptoms in selected patients with severe e
mphysema. This form of surgery is being practised in Australia with favoura
ble short-term outcomes, similar to those reported in the literature. Large
multicentre trials are currently underway in North America and the United
Kingdom to clarify issues of safety and long-term efficacy. As a result, it
is too early to apply an evidence-based approach to this procedure. In the
meantime, local audits of practice need to be undertaken to define patient
subgroups at higher risk of morbidity and mortality.